News February 16, 2021 Qiagen is interested in organic growth and acquisitions – CEO | Reuters (Reuters) - Genetic testing specialist Qiagen’s Chief Executive Thierry Bernard said the company is interested… Super User 0 Love0
News February 16, 2021 Novavax Vaccine Demonstrates Strong Immune Response – UMB News The vaccine was found to generate a robust immune response in animals exposed to the… Super User 0 Love0
News February 16, 2021 The factory that’s racing to make Johnson & Johnson’s COVID-19 vaccine – CBS News U.S. drug maker Emergent BioSolutions began speeding up its acquisition of drug supplies beginning early… Super User 0 Love0
News February 16, 2021 Solicitations – CAPCaT – CIMIT The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep… Super User 0 Love0
News February 16, 2021 1.1 Million SF of Vertical Construction Set to Begin in Port Covington • Port Covington The Port Covington Development Team consisting of lead investors Sagamore Ventures and Goldman Sachs Urban… Super User 0 Love0
News February 16, 2021 PGDx becomes latest Baltimore biotech to raise mega-deal, with $103M Series C – Baltimore Business Journal Luis Diaz, co-founder of PGDx, said the new funding will allow the company to "go… Super User 0 Love0
News February 16, 2021 Lessons learned from Johns Hopkins’ high-profile COVID-19 website | Healthcare Finance News Here's a look at how Johns Hopkins' COVID-19 website was created and how it grew… Super User 0 Love0
News February 16, 2021 These 6 pandemic fatigue-fighting creative campaigns won University System of Maryland’s Public Health Challenge – Technical.ly Baltimore University System of Maryland (USM) asked members of its community to get creative with approaches… Super User 0 Love0
News February 16, 2021 CarrTech raising funding to reach FDA finish line as Covid creates demand for needle filter system – Washington Business Journal The Montgomery County startup is raising new funding — and eyeing an eventual sale of… Super User 0 Love0
News February 16, 2021 NexImmune Announces Pricing of Upsized Initial Public Offering GAITHERSBURG, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc., a clinical-stage biotechnology company developing… Super User 0 Love0